Searched for
DELHI VACCINATION FRAUD
At Global AI Summit, India stakes claim as tech’s safe harborIndia is hosting a Global AI Summit to showcase its potential as a leading AI technology destination. The nation highlights its successful ...- 2025 Year-ender Special: From SIR and stray dogs to live-ins, top court rulings that shaped India’s legal and political debateIndia's top courts made significant rulings in 2025. The Supreme Court addressed Waqf Act amendments, stray dog management, and electoral r...
- “We are building a tech bridge between Russia and India”—Herman Gref of Sberbank on bilateral tech tiesSberbank CEO Herman Gref highlights Russia's leadership in payment technologies and generative AI, emphasizing unique solutions like biomet...
- Taranjit Singh Sandhu: He should rank among India's most successful envoys who turned the tables and changed the gameOver the years, New Delhi has sent some of its best to Washington to explain India, a country of multitudes and mysteries not intuitively u...
- Cyber fraud diminishes trust in online transactions, against aspirations of Digital Bharat: HCThe Delhi High Court's observations came while refusing to grant bail to a man, accused in a case of defrauding people of their hard earned...
- Consider discount on policy renewal for those with 3 doses of COVID-19 vaccine: Irdai to insurersDuring a meeting to create awareness about COVID-19 last week, sources said, the regulator also stressed that insurers should offer incenti...
- Suits & Sayings: A Chennai deal holds the key to a new corporate hospital in Lutyens Delhi; this VC earns bad press for SEO-jacking; legal eagle soothes founder’s pre-IPO woesA homegrown investor is finding it difficult to get quality deal flows even when having a bulge bracket backer by her side.
- View: As if the pandemic wasn't harrowing enough, fraud has now risen its ugly headDuring the worst of Covid’s ‘second wave’, Delhi and other places saw an acute shortage of oxygen. A black market erupted, where oxygen cyl...
- Stocks in the news: Nazara, Power Grid, CESC, DRL, PNB Housing, RCom and Federal BankShriram Transport Finance said it will buy back bonds issued by it in January 2019 for a limit up to Rs 450 crore.
- SAD chief Sukhbir Singh Badal says no alliance with BJP for Punjab assembly polls, slams Congress, AAPSukhbir Singh Badal, whose party was part of ruling NDA at the Centre before pulling out over the new farm laws last year, categorically ru...
- Gift of the jabAlso in today's ETtech Morning Dispatch: TCS, Infosys, Wipro and Tech Mahindra are kicking off covid vaccination drives; Social media is In...
- Centre flags first cases of vaccination fraud in DelhiThe health ministry has written to Delhi's principal secretary (health) pointing out irregularities in registration of beneficiaries at Vid...
- View: With Myanmar in balance, West must beware sledgehammer sanctionsThe thing is, Myanmar doesn’t react well to international pressure. If Myanmar is not allowed to diversify its engagement, it will end up o...
- Controversy swirls around India’s homegrown Covid-19 vaccineFrom the U.S. to the Norway, vociferous debates over the efficacy and safety of Covid-19 vaccines have beset pharmaceutical giants like Pfi...
- Will India's VIP culture disrupt the vaccination programme?For a society that loves to wear its privilege on its sleeve, the question now is whether getting the Covid vaccine long before your neighb...
- Sensex slips 45 points amid doubts over Covid vaccine; Nifty tests 13,000In the 50-share pack Nifty, Tata Motors was the biggest gainer, up 4.58 per cent. Bajaj Auto, NTPC, Britannia Industries, GAIL, Bajaj Finan...
- Stocks in focus on 26 March 2018Here is a list of top stocks that are likely to be in focus in today's trading session.
- need2know: 10 macro triggers that should matter for market todayA lowdown on top macro triggers that may move market on Tuesday.
- Pick a health card over an OPD insuranceRising healthcare costs and inadequate cover for out-patient treatment can erode your savings. Here’s a cost-effective alternative.
- Merck subsidiary plans to launch patented drugsMerck Sharp & Dohme (MSD) Pharmaceuticals is betting big on India, an emerging market for its patented and first research-based vaccines an...
Load More
